The historical rank and industry rank for Biocartis Group NV's Days Inventory or its related term are showing as below:
LTS:0R72's Days Inventory is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 68.88 * Ranked among companies with meaningful Days Inventory only.
Biocartis Group NV's Days Inventory
increased
from Jun. 2022 (239.48) to Jun. 2023 (250.93).
It might indicate that Biocartis Group NV's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Biocartis Group NV's Inventory Turnover for the
six
months ended in Jun. 2023 was 0.73.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Biocartis Group NV's Inventory-to-Revenue for the
six
months ended in Jun. 2023 was 0.62.
Biocartis Group NV (LTS:0R72) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Biocartis Group NV's Inventory Turnover for the
six
months ended in Jun. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Biocartis Group NV's Inventory to Revenue for the
six
months ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Biocartis Group NV Days Inventory Related Terms
Biocartis Group NV Days Inventory Historical Data
* Premium members only.
The historical data trend for Biocartis Group NV's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0R72 vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Biocartis Group NV's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biocartis Group NV Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Biocartis Group NV's Days Inventory distribution charts can be found below:
* The bar in red indicates where Biocartis Group NV's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biocartis Group NV (LTS:0R72) has a Days Inventory of 250.93 as of Jun. 2023. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Biocartis Group NV and its competitors.
Is Biocartis Group NV's Days Inventory too high?
Biocartis Group NV's current Days Inventory is 250.93. The Medical Diagnostics & Research industry median Days Inventory is 68.88. Biocartis Group NV's value of 250.93 is 264.3% above this industry median. Overall, Biocartis Group NV has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Biocartis Group NV's Days Inventory compare to TMO and DHR?
Biocartis Group NV's Days Inventory of 250.93 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Days Inventory is 68.88. Biocartis Group NV's value of 250.93 is 264.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 68.88, based on 178 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biocartis Group NV's current Days Inventory of 250.93 is 264.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Biocartis Group NV and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 68.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biocartis Group NV's current Days Inventory is 250.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biocartis Group NV stock overvalued right now?
Biocartis Group NV (LTS:0R72) has a current Days Inventory of 250.93. The current Days Inventory is 250.93 and 264.3% above the Medical Diagnostics & Research industry median of 68.88. Biocartis Group NV's overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Biocartis Group NV (LTS:0R72), the current Days Inventory is 250.93 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for patients, clinicians, payers, and the industry. The firm has developed an Meet Idylla molecular diagnostic system for oncology and infectious disease segments.
14GF Score
Get the complete analysis for LTS:0R72
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0R72 has been successfully added to your 
